 CUPERTINO, Calif., Jan. 04, 2023 GLOBE NEWSWIRE Reviva Pharmaceuticals Holdings, Inc. NASDAQ: RVPH Reviva or the Company, a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system CNS, cardiovascular, metabolic, and inflammatory diseases, is pleased to announce a letter to shareholders from Founder, President, ... The post Reviva Pharmaceuticals Announces Letter to Shareholders appeared first on Fore... 